Data Availability
The datasets generated and/or analyzed during the current study are not publicly available due to ethical restrictions and participant confidentiality concerns, but de-identified data are available from the corresponding author to qualified researchers on reasonable request.
Posted June 23, 2022.
SARS-CoV-2 breakthrough infection during the Delta-dominant epidemic and neutralizing antibodies against Omicron in comparison with the third dose of BNT162b2: a matched analysis
